Suppliers news and information

Texas officials on Monday refused to return lethal drugs they plan to use for an execution this week, despite a demand from the provider, which wanted to remain anonymous but has been thrust into a controversy over capital punishment.
FULL STORY »

The government shutdown isn't stopping Food and Drug Administration advisory committee meetings scheduled this month, according to drug and device manufacturers.
FULL STORY »

The Supreme Court on Monday sought the legal views of the Obama administration in a medical device manufacturer's appeal of a ruling that the company can be sued by a man who was left paralyzed after using one of its products.
FULL STORY »

The nation's most active death-penalty state has turned to a compounding pharmacy to replace its expired execution drugs, according to documents released Wednesday, weeks after Texas prison officials declined to say how they obtained the drugs amid a nationwide shortage.
FULL STORY »

PhRMA has sued to block implementation of a rule that lets providers in the 340B drug discount program buy orphan drugs at reduced prices if the drugs are used to treat non-orphan conditions.
FULL STORY »

Merck & Co. plans to cut another 8,500 jobs as the drugmaker continues its struggle with competition from cheaper generic medications that have squeezed the pharmaceutical industry for several quarters now.
FULL STORY »

A biotech drug from Roche has become the first medicine approved to treat breast cancer before surgery, offering an earlier approach against one of the deadliest forms of the disease.
FULL STORY »

In an era when the healthcare industry is no longer growing faster than the rest of the economy, it takes something special to rack up double-digit or better gains for five consecutive years. The 40 members of Modern Healthcare's 2013 class of Healthcare's Hottest met that criteria and more.
FULL STORY »

Premier, one of the nation's largest group purchasing organizations, went public today with an initial stock offering valued at $760.1 million.
FULL STORY »

The FDA would have greater oversight over large-volume compounding pharmacies like the company that triggered a deadly meningitis outbreak, under federal legislation winning bipartisan support.
FULL STORY »